Evidence map›Paper›PMID 34257812›Full record

ArticleOxidative medicine and cellular longevity2021

Poly Lactic-Co-Glycolic Acid- (PLGA-) Loaded Nanoformulation of Cisplatin as a Therapeutic Approach for Breast Cancers.

Saad Alkahtani, Saud Alarifi, Gadah Albasher, Mohammed Al-Zharani, Nada H Aljarba, Mohammed H Almarzoug, Norah M Alhoshani, Norah S Al-Johani, Hani Alothaid, Abdullah A Alkahtane

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Saad AlkahtaniDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0001-7381-5110
Saud AlarifiDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Gadah AlbasherDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Mohammed Al-ZharaniDepartment of Biology, College of Science, Imam Muhammad Ibn Saud Islamic University, Riyadh-11432, Saudi Arabia.
Nada H AljarbaDepartment of Biology, College of Sciences, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Mohammed H AlmarzougDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Norah M AlhoshaniDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Norah S Al-JohaniDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Hani AlothaidDepartment of Basic Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha-65431, Saudi Arabia.ORCID https://orcid.org/0000-0003-0132-558X
Abdullah A AlkahtaneDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite recent advancements in cisplatin (

Indexed as

Antineoplastic AgentsApoptosisBreast NeoplasmsCell Line, TumorCisplatinFemaleGlycolatesHumansPolyestersAntineoplastic AgentsCisplatinGlycolatesglycolic acidPolyesterspoly(lactide)

Identifiers

PMID34257812
PMCPMC8260288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.